Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9533047 Delivery and formulation of engineered nucleic acids

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 22, 2014
0
Date of Patent
January 3, 2017
0
Patent Application Number
14337513
0
Patent Citations Received
‌
US Patent 12133899 Coronavirus vaccine
0
‌
US Patent 12071620 Polynucleotides containing a morpholino linker
0
‌
US Patent 12090235 Preparation of lipid nanoparticles and methods of administration thereof
0
‌
US Patent 12109274 Polynucleotides containing a stabilizing tail region
0
‌
US Patent 12123012 Methods and compositions for nucleic acid and protein payload delivery
0
‌
US Patent 12128113 Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
0
‌
US Patent 11696946 Influenza vaccine
0
‌
US Patent 11744801 Methods of making lipid nanoparticles
‌
US Patent 11752206 Herpes simplex virus vaccine
‌
US Patent 11767548 RNA polymerase variants
•••
Patent Inventor Names
Antonin de Fougerolles
0
Sayda M. Elbashir
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9533047
0
Patent Primary Examiner
‌
Robert M Kelly
0

Find more entities like US Patent 9533047 Delivery and formulation of engineered nucleic acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo